Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06054646Phase 2Completed
Phase 2, open-label trial in rhytides and Hyperpigmentation (2 arms), sponsored by Egyptian Atomic Energy Authority. Primary endpoints: Wrinkle Severity Rating Scale at 2 weeks, Global Aesthetic Improvement Scale at 2 weeks and 2 more. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06054646.